Caroline Baynes

Worts Causeway
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

Journal: medRxiv : the preprint server for health sciences
Published: September 16, 2024

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

Journal: Nature communications
Published: September 02, 2024

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Journal: Nature genetics
Published: September 26, 2023

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Journal: Nature genetics
Published: June 17, 2022

Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations.

Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: December 09, 2021

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Journal: Nature communications
Published: May 15, 2021

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

Journal: The New England journal of medicine
Published: January 20, 2021

Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore.

Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore.

Journal: Journal of medical genetics
Published: September 24, 2020

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

Journal: British journal of cancer
Published: April 27, 2020

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Journal: Nature communications
Published: October 28, 2019

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Journal: Nature communications
Published: April 11, 2018

Targeted Resequencing of the Coding Sequence of 38 Genes Near Breast Cancer GWAS Loci in a Large Case-Control Study.

Targeted Resequencing of the Coding Sequence of 38 Genes Near Breast Cancer GWAS Loci in a Large Case-Control Study.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: March 27, 2018
Showing 1-12 of 38

Last Updated: 09/26/2026